FUMAGALLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 6.713
AS - Asia 3.362
EU - Europa 2.991
SA - Sud America 490
AF - Africa 65
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.653
Nazione #
US - Stati Uniti d'America 6.571
SG - Singapore 1.163
CN - Cina 911
IT - Italia 552
RU - Federazione Russa 548
HK - Hong Kong 510
DE - Germania 488
SE - Svezia 449
BR - Brasile 401
VN - Vietnam 381
IE - Irlanda 269
GB - Regno Unito 212
CA - Canada 95
IN - India 90
FR - Francia 87
UA - Ucraina 79
DK - Danimarca 66
ID - Indonesia 63
TR - Turchia 56
FI - Finlandia 41
AR - Argentina 40
AT - Austria 36
JP - Giappone 36
KR - Corea 32
LT - Lituania 32
MX - Messico 29
NL - Olanda 28
ZA - Sudafrica 28
BD - Bangladesh 23
AU - Australia 22
PL - Polonia 22
BE - Belgio 21
ES - Italia 20
EG - Egitto 17
EC - Ecuador 16
SA - Arabia Saudita 14
IQ - Iraq 12
IR - Iran 10
PY - Paraguay 10
KZ - Kazakistan 9
CH - Svizzera 8
TW - Taiwan 8
UY - Uruguay 8
CO - Colombia 7
HR - Croazia 6
PK - Pakistan 6
RO - Romania 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
EU - Europa 5
CR - Costa Rica 4
DZ - Algeria 4
ET - Etiopia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
VE - Venezuela 4
GT - Guatemala 3
IL - Israele 3
JO - Giordania 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
RS - Serbia 3
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
LB - Libano 2
MY - Malesia 2
OM - Oman 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
CL - Cile 1
CY - Cipro 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TC - Turks e Caicos 1
TG - Togo 1
TL - Timor Orientale 1
Totale 13.653
Città #
Ann Arbor 1.897
Singapore 743
Dallas 597
Hong Kong 510
Ashburn 471
Wilmington 347
Chandler 323
Frankfurt am Main 274
Dublin 261
Dearborn 236
Milan 232
Woodbridge 185
New York 176
Houston 154
Santa Clara 142
Fairfield 139
Princeton 134
Beijing 132
Nanjing 113
Los Angeles 112
Jacksonville 88
Ho Chi Minh City 87
Boardman 77
Seattle 66
Hanoi 65
Moscow 65
Guangzhou 63
Shanghai 49
Jakarta 48
Nanchang 42
Buffalo 41
Dong Ket 41
The Dalles 41
Chicago 38
Cambridge 37
São Paulo 35
Lawrence 32
Vienna 31
Munich 30
Shenyang 29
Altamura 26
Vilnius 26
Hangzhou 25
Hefei 24
Zhengzhou 24
Toronto 23
Pune 21
Shangdi 21
Jinan 20
Phoenix 20
Montreal 19
Ottawa 19
Council Bluffs 18
Denver 18
Atlanta 17
Brussels 17
Kunming 17
London 17
Sacramento 17
Sydney 16
Tianjin 16
Andover 15
Brooklyn 15
Changsha 15
Fremont 15
Rio de Janeiro 15
Tokyo 15
Warsaw 15
Falls Church 14
Kent 14
Kocaeli 14
Mainz 14
Orem 14
Portland 14
Belo Horizonte 13
Redondo Beach 13
Chennai 12
Edmonton 12
Ha Long 12
Mexico City 12
Poplar 12
San Diego 12
Haiphong 11
Helsinki 11
Jiaxing 11
Lissone 11
Nuremberg 11
Rome 11
Stockholm 11
Guarulhos 10
Johannesburg 10
Manchester 10
Norwalk 10
San Francisco 10
Turku 10
Cairo 9
Hebei 9
Lachine 9
Paris 9
Seoul 9
Totale 9.073
Nome #
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 388
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 378
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 372
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 363
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 328
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 316
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 311
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 310
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 306
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 305
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 301
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 285
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 266
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 263
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 255
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 249
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 244
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 243
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 241
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 234
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 225
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 225
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 224
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 223
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 221
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 220
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 214
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 213
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 213
Genetic factors influencing the development of vincristine-induced neurotoxicity 212
Multimodal experimental approach to the study of human neurological diseases 200
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 196
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 193
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 188
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 187
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 187
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 180
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 176
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 175
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 172
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 171
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 169
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 169
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 169
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 168
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 167
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 166
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 166
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 165
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 165
In vitro neurotoxicity of new promising metal-based anticancer complexes 163
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 163
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 161
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 160
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 159
Pharmacokinetics of IVIg in Wistar rats 157
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 156
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 151
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 141
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 139
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 137
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 134
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 133
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 131
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 127
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 127
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 126
Blood NfL as a potential axonal damage marker in different CIPN rat models. 109
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 99
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 92
Totale 14.442
Categoria #
all - tutte 47.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.462 0 0 0 0 0 216 253 252 189 148 163 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.773 139 363 248 115 236 92 189 97 286 396 222 390
2025/20263.363 754 464 855 581 633 76 0 0 0 0 0 0
Totale 14.442